Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dupixent
Pharma
Sanofi off to a promising start in launch of Dupixent for COPD
Sanofi is on a “record-setting pace,” as it relates to Medicare and commercial coverage for Dupixent in COPD, the company said.
Kevin Dunleavy
Apr 24, 2025 10:52am
FDA approves Sanofi, Regeneron’s Dupixent for hives disorder
Apr 18, 2025 11:47am
AbbVie’s Rinvoq, Skyrizi regain TV ad spending lead in February
Mar 12, 2025 10:53am
Amgen, AZ Tezspire sinusitis data invite 'best-in-disease' talk
Mar 3, 2025 11:52am
Leerink uses broad model to weigh drugs' cost-effectiveness
Feb 18, 2025 8:56am
Regeneron sues Sanofi over Dupixent commercialization discord
Feb 6, 2025 3:56pm
